Saturday 17 October 2026
Export NAKA’s income statement to Excel — free account
KindlyMD, Inc.
NAKA Financial Capital Markets
KindlyMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 million, down 33.0% from fiscal 2024. In the quarter to June 2026, revenue grew 8,680.7%, EPS grew 52.5% and free cash flow fell 25.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.13
0.96
−11.87%
Follow NAKA
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Piotroski F-Score |
3 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 |
P/S ratio |
31.51 | 2.46 | 4.06 |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
(9.29) | (7.42) | (65.32) |
P/B ratio |
0.14 | 2.60 | 0.00 |
Price to Tangible BV |
0.14 | 2.60 | 0.00 |
EV/Sales |
22.07 | 1.63 | 4.02 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.09) | (1.44) | (16.67) |
EV/FCF |
(0.07) | (1.27) | (16.42) |
Quick Ratio |
0.10 | 3.81 | 0.68 |
Current Ratio |
1.04 | 4.13 | 0.76 |
Net Debt/EBITDA |
0.12 | 0.82 | 0.21 |
Debt/Assets |
0.00% | 0.21% | 20.82% |
Debt/Equity |
0.00 | 0.00 | (2.11) |
Asset Turnover |
0.01 | 1.14 | 0.00 |
Operating CF/Net income |
0.45 | 0.85 | 0.28 |
Capex/Depreciation |
(213.60) | (0.68) | (0.06) |
Interest Coverage |
(27.92) | (8.51) | (29.04) |
| (20.21%) | (294.13%) | 0.00% | |
| (14.23%) | (151.45%) | 0.00% | |
ROIC |
(25.06%) | (691.95%) | 0.00% |
Return on Tangible Assets |
(666.87%) | (178.86%) | (4,279.10%) |
Average Days of Receivables |
0.00 | 4.95 | 2.71 |
Research and Development Expense of Revenue |
0.00% | 13.89% | 0.07% |
Selling, General and Administrative Expense of Revenue |
1,254.62% | 201.10% | 134.12% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
129.52% | 8.86% | 21.97% |
Graham Net Nets |
0.11 | 0.21 | (0.06) |
Graham Number |
0.00 | 0.00 | 17.65 |
Earnings Yield |
(247.86%) | (53.23%) | (12.54%) |
Free Cash Flow Yield |
(1,028.19%) | (51.98%) | (6.04%) |
Revenue per Share |
0.36 | 20.18 | 33.50 |
Operating CF per Share |
(4.70) | (22.80) | (4.00) |
Capex per Share |
(130.92) | (2.98) | (0.13) |
Free Cash Flow per Share |
(135.62) | (25.78) | (4.12) |
Cash per Share |
4.51 | 16.87 | 4.67 |
Shareholders Equity per Share |
102.75 | 19.05 | (0.96) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
102.75 | 19.05 | (0.96) |
Free Cash Flow |
(678.77) | (3.48) | (0.46) |
Working Capital |
7.83 | 1.90 | (0.20) |
Capital Expenditures |
(655.26) | (0.40) | (0.01) |
Net Current Asset Value |
7.47 | 1.40 | (0.59) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
359.77 | 0.15 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.00 | 4.84 | 0.95 |
Cash ROIC |
(126.44%) | (71.67%) | (71.81%) |
Accounts Receivable Turnover |
0.00 | 83.82 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.25 | 0.00 |
Inventory Turnover |
— | 2.45 | 0.00 |
Average Days of Payables |
0.00 | 1,426.94 | 532.17 |
Days of Inventory on Hand |
— | 18.96 | 101.98 |
Average Receivables |
— | 0.03 | — |
Average Payables |
3.09 | 0.33 | — |
Average Inventory |
— | 0.03 | — |
Average Assets |
367.14 | 2.39 | — |
Average Common Equity |
258.41 | 1.23 | — |
Columns are period end dates